Skip to main content
. 2015 Jun 18;10(6):e0129376. doi: 10.1371/journal.pone.0129376

Table 1. Demographic and Clinical Characteristics of the Sample and Association with Retention/Suppression Status in 2010.

Characteristics Total
N = 17,140 (%) a
R/S (N = 11,194) b R/NS (N = 3,035) b NR/S (N = 1,720) b NR/NS (N = 1,191) b
Age (years) in 2010
18–29 1,547 (9.0) 48.7% 26.5% 10.8% 14.0%
30–39 3,195 (18.6) 59.5% 20.4% 11.1% 9.0%
40–49 6,581 (38.4) 65.1% 17.4% 10.6% 7.0%
≥ 50 5,817 (33.9) 73.1% 14.2% 8.7% 4.0%
Sex
Male 12,620 (73.6) 66.6% 16.5% 10.3% 6.6%
Female 4,520 (26.4) 61.8% 21.2% 9.2% 7.8%
Race/Ethnicity
White 5,249 (30.6) 69.3% 11.9% 13.2% 5.5%
Black 7,756 (45.3) 61.0% 22.0% 8.5% 8.5%
Hispanic 3,730 (21.8) 68.8% 17.0% 8.5% 5.8%
Other/Unknown 405 (2.4) 64.0% 17.3% 12.8% 5.9%
HIV Risk Factor
MSM 6,207 (36.2) 63.1% 20.0% 9.3% 7.6%
Heterosexual 7,796 (45.5) 68.7% 14.9% 10.5% 5.9%
IDU 2,656 (15.5) 62.5% 19.5% 9.9% 8.2%
Other/Unknown 481 (2.8) 55.1% 23.1% 13.7% 8.1%
Insurance in 2010
Private 2,644 (15.4) 70.2% 12.2% 12.6% 5.1%
Medicaid 5,823 (34.0) 63.4% 22.1% 7.3% 7.2%
Medicare 3,324 (19.4) 69.4% 16.1% 8.8% 5.7%
Ryan White/Uninsured 4,773 (27.9) 53.1% 16.6% 11.9% 8.3%
Other/Unknown 576 (3.4) 56.9% 16.8% 17.2% 9.0%
First CD4 Count in 2010
≤ 200 cell/mm3 2,749 (16.0) 45.8% 33.2% 7.0% 14.0%
201–350 cell/mm3 3,228 (18.8) 63.5% 19.3% 9.1% 8.1%
351–500 cell/mm3 3,787 (22.1) 67.5% 15.7% 10.5% 6.4%
> 500 cell/mm3 7,296 (42.6) 72.6% 12.3% 11.3% 3.9%
Missing 80 (0.5) 38.8% 13.8% 20.0% 27.5%
Use of ART in 2010
No 3,573 (20.9) 10.5% 56.5% 4.8% 28.2%
Yes 13,567 (79.1) 70.1% 14.3% 10.5% 5.1%

Abbreviations: ART, antiretroviral therapy; HET, heterosexual transmission; HIV, human immunodeficiency virus; IDU, injection drug use; MSM, men who have sex with men; R = retained; S = suppressed (virologically); NR = not retained; NS = not suppressed (virologically).

All associations are statistically significant, p<0.001.

a Column percentages.

b Row percentages.